In vitro activity of roxithromycin against Moraxella catarrhalis
- 1 May 1992
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 15 (4) , 63-65
- https://doi.org/10.1016/0732-8893(92)90128-g
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Branhamella catarrhalis: an organism gaining respect as a pathogenClinical Microbiology Reviews, 1990
- Supersusceptibility to hydrophobic antimicrobial agents and cell surface hydrophobicity in Branhamella catarrhalisFEMS Microbiology Letters, 1989
- Comparative in vitro activities of new 14-, 15-, and 16-membered macrolidesAntimicrobial Agents and Chemotherapy, 1988
- Evaluation of a rapid method for identifying Branhamella catarrhalis.Journal of Clinical Pathology, 1988
- Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overviewJournal of Antimicrobial Chemotherapy, 1987
- Trimethoprim Alone Compared to Co-trimoxazole in Lower Respiratory Infections: Pharmacokinetics and Clinical EffectivenessScandinavian Journal of Infectious Diseases, 1985
- In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1984
- In vitro evaluation of three new macrolide antimicrobial agents, RU28965, RU29065, and RU29702, and comparisons with other orally administered drugsAntimicrobial Agents and Chemotherapy, 1983
- β-Lactamase-producing Branhamella catarrhalis causingotitis media in childrenThe Journal of Pediatrics, 1983
- COMPARISON OF TRIMETHOPRIM ALONE WITH TRIMETHOPRIM SULPHAMETHOXAZOLE IN THE TREATMENT OF RESPIRATORY AND URINARY INFECTIONS WITH PARTICULAR REFERENCE TO SELECTION OF TRIMETHOPRIM RESISTANCEThe Lancet, 1980